Table: Nippon Shinyaku -Q1 group results (IFRS)
Aug 7 (Reuters)-
Nippon Shinyaku Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 39.13 37.01 154.00
(+5.7 pct) (+3.9 pct) (+3.9 pct)
Operating 11.08 11.16 32.00
(-0.8 pct) (+8.6 pct) (-3.9 pct)
Pretax 11.41 11.44 32.50
(-0.3 pct) (+8.8 pct) (-3.3 pct)
Net 10.26 8.75 29.00
(+17.3 pct) (+6.1 pct) (+12.2 pct)
EPS Basic 152.40 yen 129.91 yen 430.57 yen
Ann Div 124.00 yen 124.00 yen
-Q2 Div 62.00 yen 62.00 yen
-Q4 Div 62.00 yen 62.00 yen
NOTE - Nippon Shinyaku Co Ltd.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4516.T
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)